Versant Capital Management, Inc - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$506
+172.0%
14
+180.0%
0.00%
Q1 2023$186
-78.4%
5
-73.7%
0.00%
Q4 2022$861
-78.5%
19
-64.2%
0.00%
-100.0%
Q3 2022$4,000
+100.0%
53
+120.8%
0.00%
+100.0%
Q2 2022$2,000
-77.8%
24
-59.3%
0.00%
-66.7%
Q4 2021$9,000
-10.0%
590.0%0.00%
-25.0%
Q3 2021$10,000
+900.0%
59
+1375.0%
0.00%
Q2 2021$1,0000.0%40.0%0.00%
Q1 2021$1,0000.0%4
-55.6%
0.00%
-100.0%
Q4 2019$1,0009
-25.0%
0.00%
Q3 2019$012
+200.0%
0.00%
Q1 2019$040.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders